CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
Clinical trial NCT03721757 · COMPLETED
Trial details
- NCT number
- NCT03721757
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2025-02-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.